Biopharma Software Company Aetion Announces $36 Million in Series B Funding

Retrieved on: 2018-04-11 02:45:00

Tags for this article:

Click the tags to see associated articles and topics

Biopharma Software Company Aetion Announces $36 Million in Series B Funding. View article details on hiswai:

Excerpt

<div>Aetion, a company specializing in providing real-world evidence and outcomes-based analytics solutions for the biopharma industry, has announced a whopping $36 million in Series B funding led by <b>New Enterprise Associates</b>, Amgen Ventures, Flare Capital Partners, Lakestar, and Oxeon Ventures.</div>

Article found on:

View Original Article